Published in J Clin Microbiol on November 01, 1997
Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev (2002) 2.86
Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev (1998) 2.73
New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev (2000) 1.75
Detection of cytomegalovirus in plasma and cerebrospinal fluid specimens from human immunodeficiency virus-infected patients by the AMPLICOR CMV test. J Clin Microbiol (1998) 1.01
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (1995) 34.97
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science (1996) 18.38
Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group. N Engl J Med (1996) 3.63
Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group. N Engl J Med (1995) 3.28
Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 3.23
Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis (1994) 2.60
Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis (1991) 2.43
Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis (1991) 2.36
Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol (1996) 2.26
Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. J Clin Microbiol (1994) 2.15
Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology (1988) 2.14
Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus. Proc Natl Acad Sci U S A (1985) 2.02
Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol (1995) 2.00
Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis. J Infect Dis (1995) 1.77
Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis (1995) 1.71
Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem (1995) 1.69
High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial. Ann Intern Med (1994) 1.59
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J Infect Dis (1995) 1.28
Identification of the gene product encoded by ORF UL56 of the human cytomegalovirus genome. Virology (1993) 1.28
Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J Infect Dis (1996) 1.15
The cytomegalovirus antigenemia assay: a plea for standardization. Scand J Infect Dis Suppl (1995) 1.12
Detection of ganciclovir resistance mutations quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J Infect Dis (1996) 1.11
Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med (1995) 1.09
Monitoring of renal allograft recipients by quantitation of human cytomegalovirus genomes in peripheral blood leukocytes. J Med Virol (1994) 1.08
Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J Infect Dis (1995) 1.07
Molecular detection of human cytomegalovirus and determination of genotypic ganciclovir resistance in clinical specimens. Clin Infect Dis (1995) 1.02
Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation. J Clin Microbiol (1995) 1.01
Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation. Pediatr Infect Dis J (1988) 1.01
Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation. Transplantation (1995) 0.98
Diagnosis of cytomegalovirus (CMV) polyradiculopathy and documentation of in vivo anti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays. J Infect Dis (1997) 0.97
Early detection of human cytomegalovirus viremia in bone marrow transplant recipients by DNA amplification. J Clin Microbiol (1995) 0.96
Clinical impact of cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis (1995) 0.89
Promising new treatments for cytomegalovirus retinitis. JAMA (1995) 0.82
Diagnosis and epidemiology of transfusion-associated human cytomegalovirus infection: recent developments. Infusionsther Transfusionsmed (1994) 0.79
Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med (1995) 6.90
A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res (1997) 4.40
Rapid detection and quantitation of human cytomegalovirus in urine through DNA hybridization. N Engl J Med (1983) 3.83
Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group. N Engl J Med (1996) 3.63
Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus. Appl Microbiol (1972) 3.55
Sequence of the human somatostatin I gene. Science (1984) 3.48
Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group. N Engl J Med (1995) 3.28
Chromogenic cephalosporin spot test to detect beta-lactamase in clinically significant bacteria. J Clin Microbiol (1979) 3.17
Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis (1981) 2.96
Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med (1989) 2.77
Primary lateral sclerosis. A clinical diagnosis reemerges. Arch Neurol (1988) 2.62
Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet (1982) 2.58
Pan: a transcriptional regulator that binds chymotrypsin, insulin, and AP-4 enhancer motifs. Genes Dev (1990) 2.46
Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis (1991) 2.43
Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob Agents Chemother (1991) 2.40
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis (1987) 2.32
Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. J Infect Dis (1997) 2.18
Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome? Ann Intern Med (1984) 2.07
Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis (1995) 2.07
Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol (1995) 2.00
Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy. Ann Intern Med (1993) 1.99
Comparison of the nucleic acid sequence of anglerfish and mammalian insulin mRNA's from cloned cDNA's. Science (1980) 1.92
Human somatostatin I: sequence of the cDNA. Proc Natl Acad Sci U S A (1982) 1.81
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med (1997) 1.80
Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis (1995) 1.71
Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem (1995) 1.69
An outbreak of methicillin-resistant Staphylococcus aureus infection. Observations in hospital and nursing home. JAMA (1970) 1.69
Single-copy gene detection using branched DNA (bDNA) in situ hybridization. J Histochem Cytochem (2001) 1.69
Branhamella (Neisseria) catarrhalis--a lower respiratory tract pathogen? J Clin Microbiol (1981) 1.61
Is staging beneficial for Fowler-Stephens orchiopexy? A systematic review. J Urol (2010) 1.60
Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology (1999) 1.59
Cytomegalovirus and Kaposi's sarcoma in young homosexual men. Lancet (1982) 1.59
High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial. Ann Intern Med (1994) 1.59
Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. J Infect Dis (1997) 1.56
Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir. Antimicrob Agents Chemother (1995) 1.55
Preferential accessibility of the yeast his3 promoter is determined by a general property of the DNA sequence, not by specific elements. Mol Cell Biol (2000) 1.53
Automated slide staining machine. Appl Microbiol (1972) 1.51
Patient and allograft survival of Indo Asian and East Asian dialysis patients treated in Canada. Kidney Int (2007) 1.51
Nosocomial respiratory syncytial virus infections in an intensive care nursery: rapid diagnosis by direct immunofluorescence. Pediatrics (1979) 1.49
Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatology (1995) 1.47
Efficacy of the condom as a barrier to the transmission of cytomegalovirus. J Infect Dis (1984) 1.45
Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig Dis Sci (1997) 1.44
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. J Infect Dis (1991) 1.37
Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing. Antimicrob Agents Chemother (2001) 1.36
Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1995) 1.32
The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial. J Infect Dis (1997) 1.32
Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy. J Infect Dis (1999) 1.32
Growth of herpes simplex and cytomegalovirus in cultured human alveolar macrophages. Am Rev Respir Dis (1979) 1.32
Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. J Infect Dis (2001) 1.32
Diagnosis of Pneumocystis carinii pneumonia by bronchopulmonary lavage. JAMA (1974) 1.31
Multicenter comparison of the digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia. J Clin Microbiol (1999) 1.30
Diagnostic lavage and occult pulmonary hemorrhage in thrombocytopenic immunocompromised patients. Am Rev Respir Dis (1977) 1.29
Loss of rubella antibody from immune globulin treated with kaolin. Appl Microbiol (1969) 1.29
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J Infect Dis (1995) 1.28
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1981) 1.27
An outbreak of Pneumocystis carinii pneumonia in homosexual men. Ann Intern Med (1982) 1.27
A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. Antimicrob Agents Chemother (2000) 1.27
Isolation of a new simian foamy virus from a spider monkey brain culture. Infect Immun (1973) 1.26
Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol (2003) 1.24
Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J Infect Dis (1984) 1.22
The complete nucleotide sequence of the cloned DNA of hepatitis B virus subtype adr in pADR-1. Sci Sin B (1987) 1.22
Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infections. Lancet (1981) 1.22
Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis (1994) 1.21
Evaluation of the virus permeability of a new condom for women. Sex Transm Dis (1990) 1.19
Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine. J Infect Dis (1985) 1.16
Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy. J Infect Dis (1998) 1.14
Detection of ganciclovir resistance mutations quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J Infect Dis (1996) 1.11
A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS. J Infect Dis (1997) 1.10
Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients. J Clin Microbiol (1987) 1.10
A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance. J Infect Dis (2000) 1.10
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med (1998) 1.09
Mining time dependency patterns in clinical pathways. Int J Med Inform (2001) 1.09
Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. Ann Intern Med (1985) 1.07
Cytomegalovirus infections in homosexual men. An epidemiological study. Ann Intern Med (1983) 1.06
Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group. J Infect Dis (1995) 1.06
Susceptibility of human cytomegalovirus to cidofovir is unchanged after limited in vivo exposure to various regimens of drug. J Infect Dis (1996) 1.04
Communicating hydrocephalus as a cause of aqueductal stenosis. J Neurosurg (1979) 1.04
Acquired cytomegalovirus infection in preterm infants. Am J Dis Child (1979) 1.04
Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis (1997) 1.03
Polymorphic human somatostatin gene is located on chromosome 3. Proc Natl Acad Sci U S A (1983) 1.02
Age-dependent resistance of human alveolar macrophages to herpes simplex virus. Infect Immun (1980) 1.02
Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors. Transfusion (2001) 1.02
Perspectives on switching oral acyclovir from prescription to over-the-counter status: report of a consensus panel. Clin Infect Dis (1998) 1.02
Detection of cytomegalovirus in plasma and cerebrospinal fluid specimens from human immunodeficiency virus-infected patients by the AMPLICOR CMV test. J Clin Microbiol (1998) 1.01